Evidence map›Paper›PMID 39767000›Full record

ArticleFoods (Basel, Switzerland)2024

Utilizing Lactic Acid Bacteria to Improve Hyperlipidemia: A Comprehensive Analysis from Gut Microbiota to Metabolic Pathways.

Changlu Ma, Chen Xu, Mumin Zheng, Shuwen Zhang, Qifeng Liu, Jiaping Lyu, Xiaoyang Pang, Yinghong Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Foods (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. A Rushan Acid Whey-DerivedFoods (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Impact of Dietary Interventions withFoods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. The Prophylactic Protection ofMicroorganisms · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Changlu MaDepartment of Food and Bio-Engineering, Beijing Vocational College of Agriculture, Beijing 102442, China.
Chen XuInstitute of Food Science and Technology, Chinese Academy of Agricultural Science, Beijing 100193, China.ORCID 0009-0009-2783-6186
Mumin ZhengInstitute of Food Science and Technology, Chinese Academy of Agricultural Science, Beijing 100193, China.
Shuwen ZhangInstitute of Food Science and Technology, Chinese Academy of Agricultural Science, Beijing 100193, China.ORCID 0000-0002-0064-2236
Qifeng LiuState Key Laboratory for Bioactive Substances and Functions of Natural Medicines and Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Jiaping LyuInstitute of Food Science and Technology, Chinese Academy of Agricultural Science, Beijing 100193, China.
Xiaoyang PangInstitute of Food Science and Technology, Chinese Academy of Agricultural Science, Beijing 100193, China.ORCID 0000-0003-1813-2039
Yinghong WangState Key Laboratory for Bioactive Substances and Functions of Natural Medicines and Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Funding

CHINA AGRICULTURE RESEARCH SYSTEM-NATIONAL DAIRY INDUSTRY AND TECH-NOLOGY SYSTEM CARS-36CHINA DAIRY INDUSTRY ASSOCIATION DAIRY SCIENCE AND TECHNOLOGY INNO-VATION FUND - MENGNIU SPECIAL PROJECT CDIAKCJJ-MN-2023THE CHIEF EXPERT TEAM PROJECT OF BEIJING VOCATIONAL COLLEGE OF AGRICULTURE XY-TD-22-04THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA 32172190
6 · The paper itself

Abstract

Hyperlipidemia poses significant risks for cardiovascular diseases, with emerging evidence underscoring the critical role of gut microbiota in metabolic regulation. This study explores

Indexed as

gut microbiotahyperlipidemiaLactobacillus casei CAAS36metabolomicsprobiotics

Identifiers

PMID39767000
PMCPMC11675396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.